Evaluation of MolecuLight i:X as an Adjunctive Fluorescence Imaging Tool to Clinical Signs and Symptoms for the Identification of Bacteria-containing Wounds
Status: | Recruiting |
---|---|
Conditions: | Hospital |
Therapuetic Areas: | Other |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 3/8/2019 |
Start Date: | May 23, 2018 |
End Date: | December 30, 2019 |
Contact: | Sharon McConnell, MS |
Email: | smcconnell@serenagroups.com |
Phone: | 8147063318 |
A Prospective, Single-blind, Multi-center Clinical Study Evaluating the Use of MolecuLight i:X as an Adjunctive Fluorescence Imaging Tool to Clinical Signs and Symptoms for the Identification of Bacteria-containing Wounds.
This is a non-randomized evaluation for which 160 adult patients will be imaged at outpatient
wound care clinics who present with a wound of unknown infection diagnostic status and are
receiving standard treatment. The MolecuLight i:X Imaging Device will be used as an
adjunctive tool in the assessment of the wound and may be used to guide the targeted sampling
of a wound (using a conventional punch biopsy method).
wound care clinics who present with a wound of unknown infection diagnostic status and are
receiving standard treatment. The MolecuLight i:X Imaging Device will be used as an
adjunctive tool in the assessment of the wound and may be used to guide the targeted sampling
of a wound (using a conventional punch biopsy method).
Inclusion Criteria:
- Male and female subjects presenting at an advanced outpatient wound care clinic with
wound(s) (e.g. DFU, VLU, PU, SSI)
- 18 years or older
Exclusion Criteria:
- Treatment with an investigational drug within 1 month before study enrolment
- Subjects with recent (<30 days) biopsy of target wound
- Subjects with wounds that cannot be completely imaged by study device due to anatomic
location
- Inability to consent
- Any contra-indication to routine wound care and/or monitoring
We found this trial at
14
sites
York, Pennsylvania 17403
Principal Investigator: Maria Kasper, DPM
Phone: 814-706-3318
Click here to add this to my saved trials
Athens, Georgia 30306
Principal Investigator: Rachel Hamil, MD
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Los Angeles, California 90063
Principal Investigator: Gabriel Halperin, DPM
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials